POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 94 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $109 | +91.2% | 45,542 | +40.7% | 0.00% | – |
| Q2 2023 | $57 | -82.0% | 32,368 | -68.4% | 0.00% | – |
| Q1 2023 | $316 | +2.6% | 102,545 | +76.5% | 0.00% | – |
| Q4 2022 | $308 | -99.7% | 58,109 | +84.7% | 0.00% | – |
| Q3 2022 | $111,000 | +46.1% | 31,459 | +6.3% | 0.00% | – |
| Q2 2022 | $76,000 | -50.0% | 29,601 | -13.2% | 0.00% | – |
| Q1 2022 | $152,000 | – | 34,099 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $9,254,000 | 2.96% |
| SECTORAL ASSET MANAGEMENT INC | 1,053,779 | $9,347,000 | 0.80% |
| Pentwater Capital Management LP | 4,879,490 | $43,281,000 | 0.56% |
| Vivo Capital, LLC | 926,449 | $8,218,000 | 0.48% |
| Boxer Capital, LLC | 1,251,055 | $11,097,000 | 0.38% |
| Ikarian Capital, LLC | 228,000 | $2,022,000 | 0.15% |
| Perceptive Advisors | 787,745 | $6,987,000 | 0.10% |
| Rock Springs Capital Management LP | 367,499 | $3,260,000 | 0.08% |
| PURA VIDA INVESTMENTS, LLC | 148,949 | $1,321,000 | 0.07% |
| PIPER SANDLER & CO. | 8,298 | $74,000 | 0.06% |